Vertex Pharmaceuticals Q4 2021 Earnings Preview
Vertex Pharmaceuticals (NASDAQ:VRTX) is scheduled to announce Q4 earnings results on Wednesday, January 26th, after market close.
The consensus EPS Estimate is $3.29 (+31.1% Y/Y) and the consensus Revenue Estimate is $2B (+22.7% Y/Y).
Over the last 2 years, VRTX has beaten EPS estimates 88% of the time and has beaten revenue estimates 100% of the time.

Over the last 3 months, EPS estimates have seen 14 upward revisions and 2 downward. Revenue estimates have seen 17 upward revisions and 1 downward.